Mona is a registered dietitian-nutritionist (RDN) and multiple sclerosis certified specialist (MSCS) who has been living with relapsing multiple sclerosis (MS) herself since 2008. She gets it.

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

Multiple sclerosis (MS) is a chronic inflammatory disorder that is thought to impact about 2.3 million people around the ...

The disruption of axons—the thread-like part of nerve cells that transmits electrical signals—is associated with Alzheimer's ...

A study of twins reveals two gut bacteria linked to multiple sclerosis, offering new targets for future treatments.

Multiple sclerosis (MS) is one of the most widespread disabling neurological conditions of young adults around the world, affects almost one million people in the U.S., and about 2.9 million ...

Multiple sclerosis ... specific types of brain cells in the cerebellum," Tiwari-Woodruff said. "Such research can open the door to finding ways to protect the brain early on—like boosting energy in ...

Multiple sclerosis (MS) includes both peripheral and central nervous system (CNS) inflammation, and an anti-inflammatory small molecule therapy that can cross the blood-brain barrier may be ...

Multiple sclerosis is an autoimmune disease in which immune cells attack and destroy the protective myelin sheaths that surround nerve fibres, leading to neurological disturbances. Some brain ...

To celebrate the luncheon's 10th year, the National Multiple Sclerosis Society, a nonprofit with an office in Hauppauge, wanted to do something different, so she suggested a fashion show.

TORONTO, June 17, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to ...